The rationale for conducting the proposed study on the efficacy and safety of prebiotic supplementation in individuals depend on several factors. The gut microbiota, once established, undergoes dynamic changes throughout a person’s life. Despite its variability, alterations in gut microbiota composition have profound implications for the development of various diseases, ranging from chronic gastrointestinal disorders to neurological conditions (55). It is important to evaluate gut microbiota composition and its relationship with the human health–disease condition, as well as the effect of consumption of prebiotic supplement on the balance of its composition. There is growing evidence suggesting that alterations in the gut microbiota composition (dysbiosis), may give rise to various digestive issues such as irritable bowel syndrome, constipation, diarrhea, heartburn, or bloating.

The prevalence of GI diseases has increased in recent years, largely attributed to significant lifestyle changes. Studies have revealed a strong association between GI disorders and mental health issues, including depression, stress, anxiety, and impaired central nervous system function (56). While dietary interventions are a cornerstone of gut health and inflammation management, long-term success is often challenging to achieve. Therefore, exploring adjunct approach such as prebiotic and gut detox supplementation could offer additional strategies for improving gut detoxification and digestion, potentially influencing metabolic outcomes. Boosting the beneficial bacteria in the digestive tract and gut detoxification help to provide relief from digestive issues. Undergoing gut cleansing i.e. detoxification improves digestion, repairs existing damage to the intestines and restore healthy intestinal function.

Moreover, evaluating the safety of prebiotic supplementation is essential particularly in gut health and inflammation management where individuals may have underlying health conditions or be taking multiple medications. If interventional supplement is found to be effective and safe alternative, they could be incorporated into treatment protocols of various gastric disorders, offering participant s additional options for achieving and maintaining digestive health.

Overall, this randomized, double-blind, placebo-controlled clinical trial investigating the efficacy of prebiotic colon detox shots would fill a significant knowledge gap in the field of digestive health and gut function. The findings could contribute to a better understanding of the population health burden associated with digestive diseases and inform the development of strategies to reduce the overall disease burden. The major goals of the investigational product are to reduce inflammation, support gut health, and improve digestion by removing inflammatory foods and replacing them with nourishing, digestible options. Additionally, the product seeks to consolidate the positive changes achieved during the cleanse by promoting long-term gut health through balanced nutrition and healthy lifestyle practices.

RESULTS

A total of 63 participants completed the study and were included in the final analysis (intervention: n=32; placebo: n=31). Baseline demographic and clinical characteristics were comparable between groups.

CONCLUSION 

In this randomized, double-blind, placebo-controlled trial, a 14-day prebiotic–botanical formulation resulted in clinically meaningful improvements in gastrointestinal symptoms, bowel habits, and gastrointestinal-related quality of life in adults with mild functional digestive complaints. By Day 15, the intervention produced approximately 70–80% improvement in validated symptom scores, including pronounced reductions in bloating, abdominal pain, reflux, and indigestion, with good tolerability and no safety concerns. These findings support the short-term use of the formulation as a non-pharmacological approach for digestive symptom relief and bowel function support.